[4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid

C48H46Cl2F6N8O7 — CID 161427357

IUPAC[4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid
SMILESCC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)c(C(F)(F)F)c3)cc3cccnc32)C1.CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)O)cc3cccnc32)C1.NCc1ccc(Cl)c(C(F)(F)F)c1
InChIInChI=1S/C24H22ClF3N4O3.C16H17N3O4.C8H7ClF3N/c1-23(2)12-31(13-23)19(33)11-32-20-15(4-3-7-29-20)9-16(22(32)35)21(34)30-10-14-5-6-18(25)17(8-14)24(26,27)28;1-16(2)8-18(9-16)12(20)7-19-13-10(4-3-5-17-13)6-11(14(19)21)15(22)23;9-7-2-1-5(4-13)3-6(7)8(10,11)12/h3-9H,10-13H2,1-2H3,(H,30,34);3-6H,7-9H2,1-2H3,(H,22,23);1-3H,4,13H2
InChIKeyVXNRJRFWIMOZBS-UHFFFAOYSA-N
MW1031.84 g/mol
LogP7.65
Rot. Bonds9

About [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid

[4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid (PubChem CID 161427357) has the molecular formula C48H46Cl2F6N8O7 and a molecular weight of 1031.84 g/mol. Its IUPAC name is [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid.

Molecular Properties

Compound Name[4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid
PubChem CID161427357
Molecular FormulaC48H46Cl2F6N8O7
Molecular Weight1031.84 g/mol
Exact Mass1030.28
IUPAC Name[4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid
SMILESCC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)c(C(F)(F)F)c3)cc3cccnc32)C1.CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)O)cc3cccnc32)C1.NCc1ccc(Cl)c(C(F)(F)F)c1
InChIInChI=1S/C24H22ClF3N4O3.C16H17N3O4.C8H7ClF3N/c1-23(2)12-31(13-23)19(33)11-32-20-15(4-3-7-29-20)9-16(22(32)35)21(34)30-10-14-5-6-18(25)17(8-14)24(26,27)28;1-16(2)8-18(9-16)12(20)7-19-13-10(4-3-5-17-13)6-11(14(19)21)15(22)23;9-7-2-1-5(4-13)3-6(7)8(10,11)12/h3-9H,10-13H2,1-2H3,(H,30,34);3-6H,7-9H2,1-2H3,(H,22,23);1-3H,4,13H2
InChIKeyVXNRJRFWIMOZBS-UHFFFAOYSA-N
XLogP7.65
TPSA202.82 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms71
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001031.84
LogP ≤ 57.65
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid?
The IUPAC name of [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid (CID 161427357) is [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid.
What is the SMILES notation for [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid?
The canonical SMILES for [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid is CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)c(C(F)(F)F)c3)cc3cccnc32)C1.CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)O)cc3cccnc32)C1.NCc1ccc(Cl)c(C(F)(F)F)c1.
What is the InChIKey of [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid?
The InChIKey is VXNRJRFWIMOZBS-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22ClF3N4O3.C16H17N3O4.C8H7ClF3N/c1-23(2)12-31(13-23)19(33)11-32-20-15(4-3-7-29-20)9-16(22(32)35)21(34)30-10-14-5-6-18(25)17(8-14)24(26,27)28;1-16(2)8-18(9-16)12(20)7-19-13-10(4-3-5-17-13)6-11(14(19)21)15(22)23;9-7-2-1-5(4-13)3-6(7)8(10,11)12/h3-9H,10-13H2,1-2H3,(H,30,34);3-6H,7-9H2,1-2H3,(H,22,23);1-3H,4,13H2.
What are the key properties of [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid?
[4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid has a molecular weight of 1031.84 g/mol, XLogP of 7.65, 9 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [4-chloro-3-(trifluoromethyl)phenyl]methanamine;N-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylic acid is sourced from PubChem (CID 161427357), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).